- Home
- XXII vs ALBT Comparison
XXII vs ALBT Comparison
Compare XXII & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- ALBT
- Stock Information
- Founded
- XXII 1998
- ALBT 2014
- Country
- XXII United States
- ALBT United States
- Employees
- XXII N/A
- ALBT N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XXII Health Care
- ALBT Health Care
- Exchange
- XXII Nasdaq
- ALBT Nasdaq
- Market Cap
- XXII 2.8M
- ALBT 3.1M
- IPO Year
- XXII N/A
- ALBT N/A
- Fundamental
- Price
- XXII $3.15
- ALBT $5.42
- Analyst Decision
- XXII
- ALBT
- Analyst Count
- XXII 0
- ALBT 0
- Target Price
- XXII N/A
- ALBT N/A
- AVG Volume (30 Days)
- XXII 166.3K
- ALBT 27.1K
- Earning Date
- XXII 03-27-2025
- ALBT 04-14-2025
- Dividend Yield
- XXII N/A
- ALBT N/A
- EPS Growth
- XXII N/A
- ALBT N/A
- EPS
- XXII N/A
- ALBT N/A
- Revenue
- XXII $17,304,000.00
- ALBT N/A
- Revenue This Year
- XXII $56.94
- ALBT N/A
- Revenue Next Year
- XXII $2.98
- ALBT N/A
- P/E Ratio
- XXII N/A
- ALBT N/A
- Revenue Growth
- XXII N/A
- ALBT N/A
- 52 Week Low
- XXII $3.01
- ALBT $2.11
- 52 Week High
- XXII $581.85
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- XXII 35.94
- ALBT 78.62
- Support Level
- XXII $3.01
- ALBT $3.33
- Resistance Level
- XXII $3.47
- ALBT $3.73
- Average True Range (ATR)
- XXII 0.33
- ALBT 0.35
- MACD
- XXII 0.11
- ALBT 0.19
- Stochastic Oscillator
- XXII 11.29
- ALBT 91.63
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.